Portal de Periódicos da CAPES

HPV vaccination of immunocompromised hosts

2017; Elsevier BV; Volume: 4; Linguagem: Inglês

10.1016/j.pvr.2017.06.002

2405-8521

Suzanne M. Garland, Julia Brotherton, A.-B. Moscicki, Andreas M. Kaufmann, Margaret Stanley, Neerja Bhatla, Rengaswamy Sankaranarayanan, Sílvia de Sanjosé, Joel M. Palefsky,

Herpesvirus Infections and Treatments

It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.